| Price | 54.50p on 13-01-2026 at 19:40:05 |
|---|---|
| Change | -1.50p -2.68% |
| Buy | 56.00p |
| Sell | 53.00p |
| Last Trade: | Unknown 50,000.00 at 54.50p |
| Day's Volume: | 3,389,096 |
| Last Close: | 54.50p |
| Open: | 56.00p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 52.50p - 56.50p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £236.35m |
| VWAP: | 54.45844p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 50,000 | 54.50p | OTC Trade |
17:07:35 - 13-Jan-26 |
| Sell* | 2,804 | 53.77p | Ordinary |
16:28:44 - 13-Jan-26 |
| Sell* | 2,798 | 53.77p | Ordinary |
16:24:47 - 13-Jan-26 |
| Buy* | 2,710 | 54.8973p | Ordinary |
16:22:13 - 13-Jan-26 |
| Buy* | 4,546 | 54.8973p | Ordinary |
16:18:55 - 13-Jan-26 |
| Buy* | 87 | 54.8973p | Ordinary |
16:14:50 - 13-Jan-26 |
| Buy* | 1 | 54.90p | Ordinary |
16:13:56 - 13-Jan-26 |
| Buy* | 69 | 54.90p | Ordinary |
16:12:43 - 13-Jan-26 |
| Sell* | 1,385 | 53.65p | Ordinary |
16:11:38 - 13-Jan-26 |
| Buy* | 36 | 55.3972p | Ordinary |
16:04:56 - 13-Jan-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 18th Dec 2025 7:00 am | RNS-R | Avacta reports new AVA6103 pharmacology data |
| 17th Dec 2025 7:00 am | RNS | Faridoxorubicin Phase 1b SGC data |
| 8th Dec 2025 7:00 am | RNS | Preliminary Data in Faridoxorubicin Phase 1b Trial |
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
